ASCO 2026 Highlights Global Shift in Oncology Innovation
The upcoming ASCO 2026 conference is set to reveal significant shifts in global oncology innovation, with a notable increase in assets originating from China. This trend reflects a broader distribution of oncology innovation, challenging traditional pharma models. The conference will showcase how companies are aligning R&D, communications, and commercial strategies more closely, with a focus on faster localization and market response. The shift is compared to the automotive industry's evolution in the 1970s, highlighting the need for pharma to adapt to a more interconnected global market. 
